OM
Opaleye Management Inc. bought $32K of GRCE stock
Opaleye Management Inc., 10% owner of Grace Therapeutics, Inc. (GRCE), bought 15,089 shares of GRCE stock worth $32K, per an SEC Form 4 filed Sep 23, 2026.
It was an open-market purchase.
The trade happened on Sep 21, 2026, 2 days before it was made public.
GRCE has moved -11.9% since the trade date, from $2.10 to $1.85 (Nov 6, 2026 close).
- Traded
- Sep 21, 2026
- Disclosed
- Sep 23, 2026
- Filing delay
- 2 days
- Price since
- -11.9%
- Role
- 10% owner
- Source
- SEC Form 4